Genflow Bioscience

Podcast

A Disruptive Approach to Longevity Therapies

At Ending Age-Related Diseases 2020, Dr. Eric Leire of Genflow Biosciences discussed his company, explaining what Genflow does and how it is funded. The company is intervening directly in the biology of aging, affecting SIRT6, which, like other sirtuins, is a known regulator of aging. The company intends to develop its SIRT6 plasmid as an epigenomic therapy that will affect downstream hallmarks of aging, potentially providing a broad-based solution to multiple age-related diseases.

 

Share it online!

If you enjoyed the article why not share it with your friends! There’s plenty more to read!

Share on facebook
Share on twitter
Share on linkedin

Related Articles

An Audience with Dr Eric Leire

Genflow Biosciences are an exciting business that are unlocking the secret to human longevity. Join us as Dr Eric Leire explains exactly how they are doing this and how in the future they plan to make your Mum, Dad or Dog live longer.

Read More...

Stay up to date with our progress, news and more